Aktualija 1
Ut enim ad minim veniam
As an emergency medicine clinician in Madrid, Spain, Dr. Yale Tung Chen has treated many COVID-19 patients since the start of the pandemic. And when he developed last March the ominous constellation of symptoms caused by the SARS-CoV-2 coronavirus — chills, cough, low-grade fever and a nagging headache — he knew what to do. Like other people stricken by the disease, the physician quarantined at home and monitored the signs of his illness. But he also knew that his overt symptoms were not the full picture of the disease. The virus could be also lurking in his lungs, heart and other organs. Getting that information quickly with a handheld ultrasound system could affect prognosis and treatment.
After he recovered and returned to the hospital, Tung Chen became one of a handful of clinicians around the world testing Vscan Air™, a pocket-sized, wireless ultrasound scanner developed by engineers at GE Healthcare. The device beams images from the ultrasound probe to an app on his smartphone. “The images you can get of the heart on this handheld device are similar to what you’d get from a full-size, high-end ultrasound,” he says.
He quickly started using the new device on his daily rounds. “I just carry it in my white coat pocket and start to scan right at the moment when I see a patient,” he said. “I’ve been using it on COVID-19 patients, scanning hearts, lungs, blocked vessels, any organ in the body I could reach. It allows me to quickly perform a complete exam on my patient and make decisions quickly right at the bedside.”
Soon other clinicians will have the same opportunity. GE unveiled the device on Tuesday. It’s for sale in the U.S. and Europe. Anders Wold, president and CEO of global ultrasound at GE Healthcare, said Vscan Air will increase access to more personalized medical care and help improve efficiency inside the hospital and anywhere in the field*. “We pioneered handheld ultrasound when we brought the first pocket-sized, color device to market, and now we see Vscan Air as delivering on the future of healthcare at a time when ultrasound has proven to be an essential tool at the point of care,” Wold said.
Lorem ipsum dolor sit amet, consectetur
- Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
- Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit
As an emergency medicine clinician in Madrid, Spain, Dr. Yale Tung Chen has treated many COVID-19 patients since the start of the pandemic. And when he developed last March the ominous constellation of symptoms caused by the SARS-CoV-2 coronavirus — chills, cough, low-grade fever and a nagging headache — he knew what to do. Like other people stricken by the disease, the physician quarantined at home and monitored the signs of his illness. But he also knew that his overt symptoms were not the full picture of the disease. The virus could be also lurking in his lungs, heart and other organs. Getting that information quickly with a handheld ultrasound system could affect prognosis and treatment.
After he recovered and returned to the hospital, Tung Chen became one of a handful of clinicians around the world testing Vscan Air™, a pocket-sized, wireless ultrasound scanner developed by engineers at GE Healthcare. The device beams images from the ultrasound probe to an app on his smartphone. “The images you can get of the heart on this handheld device are similar to what you’d get from a full-size, high-end ultrasound,” he says.
He quickly started using the new device on his daily rounds. “I just carry it in my white coat pocket and start to scan right at the moment when I see a patient,” he said. “I’ve been using it on COVID-19 patients, scanning hearts, lungs, blocked vessels, any organ in the body I could reach. It allows me to quickly perform a complete exam on my patient and make decisions quickly right at the bedside.”
Soon other clinicians will have the same opportunity. GE unveiled the device on Tuesday. It’s for sale in the U.S. and Europe. Anders Wold, president and CEO of global ultrasound at GE Healthcare, said Vscan Air will increase access to more personalized medical care and help improve efficiency inside the hospital and anywhere in the field*. “We pioneered handheld ultrasound when we brought the first pocket-sized, color device to market, and now we see Vscan Air as delivering on the future of healthcare at a time when ultrasound has proven to be an essential tool at the point of care,” Wold said.
Soon other clinicians will have the same opportunity. GE unveiled the device on Tuesday. It’s for sale in the U.S. and Europe. Anders Wold, president and CEO of global ultrasound at GE Healthcare, said Vscan Air will increase access to more personalized medical care and help improve efficiency inside the hospital and anywhere in the field*. “We pioneered handheld ultrasound when we brought the first pocket-sized, color device to market, and now we see Vscan Air as delivering on the future of healthcare at a time when ultrasound has proven to be an essential tool at the point of care,” Wold said.
Šaltinis lorem ipsum